TrademarkDir
SCRIBE
LIVE

Serial Number

88188800

Owner

Scribe Therapeutics Inc.

Attorney

John Paul Oleksiuk

First Use Date

Oct 1, 2020

Filing Date

Nov 9, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SCRIBE Trademark

Serial Number: 88188800 • Registration: 6775193

SCRIBE is a trademark filed by Scribe Therapeutics Inc. on November 9, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Scribe Therapeutics Inc. (10 trademarks)

Alameda, CA 94501

Entity Type: 03

Trademark Details

Filing Date

November 9, 2018

Registration Date

June 28, 2022

First Use Anywhere

October 1, 2020

First Use in Commerce

October 1, 2020

Published for Opposition

March 26, 2019

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 28, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 28, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 27, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 26, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 25, 2022 SUPC
USE AMENDMENT FILED
May 20, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
May 20, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2021 EXRA
SOU EXTENSION 5 GRANTED
Nov 29, 2021 EX5G
SOU EXTENSION 5 FILED
Nov 16, 2021 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 16, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 19, 2021 EXRA
SOU EXTENSION 4 GRANTED
May 17, 2021 EX4G
SOU EXTENSION 4 FILED
May 17, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
May 17, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2020 EXRA
SOU EXTENSION 3 GRANTED
Nov 9, 2020 EX3G
SOU EXTENSION 3 FILED
Nov 9, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 9, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2020 EXRA
SOU EXTENSION 2 GRANTED
Apr 17, 2020 EX2G
SOU EXTENSION 2 FILED
Apr 17, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 17, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2020 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 25, 2020 AITU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 3, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 3, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 3, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2019 EXRA
SOU EXTENSION 1 GRANTED
Oct 18, 2019 EX1G
SOU EXTENSION 1 FILED
Oct 18, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 18, 2019 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 19, 2019 CHAN
ASSIGNED TO LIE
Sep 19, 2019 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 16, 2019 EWAF
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 21, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2019 CNSA
ASSIGNED TO EXAMINER
Feb 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 28, 2018 NWOS
NEW APPLICATION ENTERED
Nov 13, 2018 NWAP

Related Trademarks

More from this Owner

CRISPR BY DESIGN

CRISPR BY DESIGN

ELXR

ELXR

ELXR

ELXR

X SCRIBE THERAPEUTICS logo

X SCRIBE THERAPEUTICS

X SCRIBE THERAPEUTICS logo

X SCRIBE THERAPEUTICS

X SCRIBE THERAPEUTICS logo

X SCRIBE THERAPEUTICS